Nexus AG (0FGL.L)
EUR 68.83
(0.34%)
EUR 68.83
(0.34%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.39 EUR | 14.88% |
| 2022 | 1.21 EUR | 11.01% |
| 2021 | 1.09 EUR | 14.74% |
| 2020 | 0.95 EUR | 37.68% |
| 2019 | 0.69 EUR | 0.0% |
| 2018 | 0.69 EUR | 9.52% |
| 2017 | 0.63 EUR | 21.15% |
| 2016 | 0.52 EUR | 6.12% |
| 2015 | 0.49 EUR | -10.91% |
| 2014 | 0.55 EUR | 14.58% |
| 2013 | 0.48 EUR | 14.29% |
| 2012 | 0.42 EUR | 27.27% |
| 2011 | 0.33 EUR | 32.0% |
| 2010 | 0.25 EUR | 66.67% |
| 2009 | 0.15 EUR | 36.36% |
| 2008 | 0.11 EUR | 37.5% |
| 2007 | 0.08 EUR | 60.0% |
| 2006 | 0.05 EUR | 150.0% |
| 2005 | 0.02 EUR | 152.36% |
| 2004 | -0.04 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.46 EUR | 35.29% |
| 2024 Q1 | 0.38 EUR | 2.7% |
| 2024 Q2 | 0.34 EUR | -10.53% |
| 2023 Q1 | 0.33 EUR | -2.94% |
| 2023 Q4 | 0.37 EUR | -5.13% |
| 2023 FY | - EUR | 14.88% |
| 2023 Q3 | 0.39 EUR | 30.0% |
| 2023 Q2 | 0.30 EUR | -9.09% |
| 2022 Q2 | 0.31 EUR | 19.23% |
| 2022 Q1 | 0.26 EUR | -35.0% |
| 2022 Q4 | 0.34 EUR | 21.43% |
| 2022 FY | - EUR | 11.01% |
| 2022 Q3 | 0.28 EUR | -9.68% |
| 2021 FY | - EUR | 14.74% |
| 2021 Q3 | 0.22 EUR | -12.0% |
| 2021 Q2 | 0.25 EUR | 8.7% |
| 2021 Q4 | 0.40 EUR | 81.82% |
| 2021 Q1 | 0.23 EUR | -41.03% |
| 2020 Q1 | 0.19 EUR | -29.63% |
| 2020 FY | - EUR | 37.68% |
| 2020 Q4 | 0.39 EUR | 129.41% |
| 2020 Q3 | 0.17 EUR | -15.0% |
| 2020 Q2 | 0.20 EUR | 5.26% |
| 2019 Q4 | 0.27 EUR | 80.0% |
| 2019 Q3 | 0.15 EUR | 66.67% |
| 2019 Q2 | 0.09 EUR | -50.0% |
| 2019 FY | - EUR | 0.0% |
| 2019 Q1 | 0.18 EUR | -5.26% |
| 2018 Q3 | 0.18 EUR | 20.0% |
| 2018 Q2 | 0.15 EUR | -11.76% |
| 2018 Q1 | 0.17 EUR | 0.0% |
| 2018 Q4 | 0.19 EUR | 5.56% |
| 2018 FY | - EUR | 9.52% |
| 2017 Q1 | 0.15 EUR | 25.0% |
| 2017 FY | - EUR | 21.15% |
| 2017 Q2 | 0.15 EUR | 0.0% |
| 2017 Q3 | 0.16 EUR | 6.67% |
| 2017 Q4 | 0.17 EUR | 6.25% |
| 2016 Q1 | 0.14 EUR | 68.67% |
| 2016 Q4 | 0.12 EUR | 0.0% |
| 2016 Q3 | 0.12 EUR | -14.29% |
| 2016 Q2 | 0.14 EUR | 0.0% |
| 2016 FY | - EUR | 6.12% |
| 2015 FY | - EUR | -10.91% |
| 2015 Q4 | 0.08 EUR | -30.83% |
| 2015 Q3 | 0.12 EUR | -14.29% |
| 2015 Q2 | 0.14 EUR | 0.0% |
| 2015 Q1 | 0.14 EUR | -22.22% |
| 2014 Q4 | 0.18 EUR | 63.64% |
| 2014 Q3 | 0.11 EUR | -15.38% |
| 2014 Q2 | 0.13 EUR | 0.0% |
| 2014 FY | - EUR | 14.58% |
| 2014 Q1 | 0.13 EUR | -7.14% |
| 2013 Q3 | 0.11 EUR | 0.0% |
| 2013 Q1 | 0.12 EUR | 21.21% |
| 2013 FY | - EUR | 14.29% |
| 2013 Q4 | 0.14 EUR | 27.27% |
| 2013 Q2 | 0.11 EUR | -8.33% |
| 2012 Q1 | 0.10 EUR | 33.33% |
| 2012 Q2 | 0.11 EUR | 10.0% |
| 2012 Q3 | 0.12 EUR | 9.09% |
| 2012 Q4 | 0.10 EUR | -17.5% |
| 2012 FY | - EUR | 27.27% |
| 2011 FY | - EUR | 32.0% |
| 2011 Q1 | 0.08 EUR | 9.59% |
| 2011 Q4 | 0.08 EUR | 7.14% |
| 2011 Q2 | 0.11 EUR | 37.5% |
| 2011 Q3 | 0.07 EUR | -36.36% |
| 2010 Q2 | 0.07 EUR | 40.0% |
| 2010 Q3 | 0.07 EUR | 0.0% |
| 2010 Q4 | 0.07 EUR | 4.29% |
| 2010 Q1 | 0.05 EUR | -5.66% |
| 2010 FY | - EUR | 66.67% |
| 2009 Q2 | 0.03 EUR | 0.0% |
| 2009 Q1 | 0.03 EUR | 0.0% |
| 2009 FY | - EUR | 36.36% |
| 2009 Q4 | 0.05 EUR | 32.5% |
| 2009 Q3 | 0.04 EUR | 33.33% |
| 2008 FY | - EUR | 37.5% |
| 2007 FY | - EUR | 60.0% |
| 2006 FY | - EUR | 150.0% |
| 2005 FY | - EUR | 152.36% |
| 2004 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Cegedim SA | -0.54 EUR | 357.407% |
| Guerbet SA | 1.90 EUR | 26.842% |
| Bastide Le Confort Médical SA | -0.12 EUR | 1258.333% |
| Revenio Group Oyj | 0.72 EUR | -93.056% |
| Drägerwerk AG & Co. KGaA | 5.89 EUR | 76.401% |
| Sartorius Aktiengesellschaft | 3.00 EUR | 53.667% |
| LNA Santé SA | 2.29 EUR | 39.301% |
| Siemens Healthineers AG | 1.74 EUR | 20.115% |
| Medios AG | 0.79 EUR | -75.949% |
| Equasens Société anonyme | 3.13 EUR | 55.591% |
| Stratec SE | 1.07 EUR | -29.907% |